Improving Safe Use of Medications During Pregnancy: The Roles of Patients, Physicians, and Pharmacists

被引:25
|
作者
Lynch, Molly M. [1 ]
Amoozegar, Jacqueline B. [1 ]
McClure, Emily M. [1 ]
Squiers, Linda B. [1 ]
Broussard, Cheryl S. [2 ,3 ]
Lind, Jennifer N. [2 ,3 ]
Polen, Kara N. [2 ,3 ]
Frey, Meghan T. [2 ,3 ]
Gilboa, Suzanne M. [2 ,3 ]
Biermann, Janis [4 ]
机构
[1] RTI Int, Res Triangle Pk, NC USA
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
[3] US PHS, Atlanta, GA USA
[4] March Dimes Fdn, White Plains, NY USA
关键词
doctor-patient; nurse-patient; communication; decision making; patient; education; information seeking; health; pregnancy; reproduction; qualitative; triangulation; United States; POTENTIALLY TERATOGENIC MEDICATIONS; CLINICAL DECISION-SUPPORT; INDUCED BIRTH-DEFECTS; WOMENS EXPERIENCES; REPRODUCTIVE-AGE; PRIMARY-CARE; KNOWLEDGE; RISKS; CONTRACEPTION; OBSTETRICIAN;
D O I
10.1177/1049732317732027
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our study sought to explore the actual and potential roles of patients, physicians, and pharmacists, as well as their shared challenges and opportunities, in improving the safety of medication use during pregnancy. We conducted virtual focus groups with 48 women and in-depth interviews with nine physicians and five pharmacists. Qualitative analysis revealed that all three groups of participants reported playing it safe, the need for an engaged patient making informed decisions, challenges surrounding communication about pregnancy status, and a lack of patient-centric resources. Patients, physicians, and pharmacists are highly motivated to protect developing babies from potential harms of medication use during pregnancy while maintaining the patient's health. Strategic messaging could maximize the effectiveness of these interactions by helping physicians discuss the benefits and risks of medication use during pregnancy, pharmacists screen for pregnancy and counsel on medication safety, and patients using medications to share pregnancy intentions with their providers pre-pregnancy.
引用
收藏
页码:2071 / 2080
页数:10
相关论文
共 50 条
  • [31] Are probiotics safe for use during pregnancy and lactation?
    Elias, Jackie
    Bozzo, Pina
    Einarson, Adrienne
    CANADIAN FAMILY PHYSICIAN, 2011, 57 (03) : 299 - 301
  • [32] The Use of ERCP during Pregnancy: Is it Safe and Effective?
    Akcakaya, Adem
    Koc, Bora
    Adas, Gokhan
    Kemik, Ozgur
    HEPATO-GASTROENTEROLOGY, 2014, 61 (130) : 296 - 298
  • [33] Safe use of valproic acid during pregnancy
    Koren, G
    Kennedy, D
    CANADIAN FAMILY PHYSICIAN, 1999, 45 : 1451 - 1453
  • [34] Ensuring the safe use of medication during pregnancy
    Dizengremel, Sarah
    Desmouliere, Alexis
    Coubret, Anne
    Fougere, Edouard
    ACTUALITES PHARMACEUTIQUES, 2019, 58 (591): : 12 - 14
  • [35] Comment: Paroxetine use during pregnancy: Is it safe?
    Wood, Wende
    Einarson, Adrienne
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (12) : 2281 - 2282
  • [36] Are Psychotropic Drugs Safe to Use During Pregnancy?
    Shah, Asim A.
    Khawaja, Imran S.
    Aftab, Awais
    PSYCHIATRIC ANNALS, 2015, 45 (02) : 71 - 76
  • [37] Outcomes associated with the use of medications for opioid use disorder during pregnancy
    Krans, Elizabeth E.
    Kim, Joo Yeon
    Chen, Qingwen
    Rothenberger, Scott D.
    James, Alton Everette
    Kelley, David
    Jarlenski, Marian P.
    ADDICTION, 2021, 116 (12) : 3504 - 3514
  • [38] Community pharmacists' actions when patients use complementary and alternative therapies with medications
    Brown, CM
    Barner, JC
    Shah, S
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2005, 45 (01) : 41 - 47
  • [39] Perinatal Mental Illness and the Use of Psychotropic Medications During Pregnancy
    Tracy, Kevyn
    JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2023, 52 (04): : S49 - S49
  • [40] The Use of Antiasthmatic Medications During Pregnancy and the Risk of Gestational Diabetes
    Baribeau, Veronique
    Beauchesne, Marie-France
    Rey, Evelyne
    Forget, Amelie
    Blais, Lucie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 266 - 267